Company / Return on Assets (ROA)
Anika Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-5.7%
FY2025
5-year range
-30.6% / 7.8%
FY2021-FY2025
Trend
+79.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -30.6% in FY2023 to 16.0% in FY2016.
Based on SEC 10-K filings.
-5.7% in FY2025 with a 5-year CAGR of -11.4%.
Improved from -30.6% to -5.7% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +1.1pp
- 5-Year Change
- -11.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 79.4% year-over-year.
- Peak return on assets (roa) was recorded in FY2016.
- Lowest return on assets (roa) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5.7% | +79.4% |
| FY2024 | -27.8% | +9.0% |
| FY2023 | -30.6% | -344.7% |
| FY2022 | -6.9% | -187.9% |
| FY2021 | 7.8% | +38.2% |
| FY2020 | 5.7% | -41.2% |
| FY2019 | 9.6% | -17.6% |
| FY2018 | 11.7% | +7.3% |
| FY2017 | 10.9% | -31.8% |
| FY2016 | 16.0% | +82.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026